According to a study by Lai et al., SGLT1 can act as an independent unfavorable prognostic marker for ovarian cancer [21], whereas another group found that high SGLT1 expression in pancreatic cancer was significantly associated with longer DFS in younger patients [25]. This evidence concerns the gene SLC5A1 and ovarian cancer.